Moffitt Cancer Center, a leading National Cancer Institute-designated comprehensive cancer centre, has announced a strategic partnership with Cryoport, Inc., a global leader in supply chain solutions for the life sciences sector. The collaboration will see Cryoport’s CRYOGENE business unit provide
Cryoport, Inc., a global provider of supply chain solutions for the life sciences industry, has announced FDA registration of its subsidiary, MVE Biological Solutions, across three manufacturing facilities. The registered sites are located in Ball Ground, Georgia; New Prague, Minnesota;
Cryoport, Inc., a global supply chain solutions provider for life sciences, has opened its new IntegriCell™ facility in Belgium to support cell therapy programs with cryopreservation services. The facility, located in Villers-le-Bouillet, aims to enhance the cryopreservation of leukapheresis materials,
Cryoport, Inc. has announced a new strategic partnership with VGXI, Inc., aimed at bolstering supply chain services for biopharmaceutical companies developing cell and gene therapies, as well as mRNA-based treatments. The collaboration will leverage Cryoport’s biostorage and bioservices to manage
Cryoport, a provider of supply chain solutions for the life sciences, has partnered with Minaris Regenerative Medicine Co., Ltd., a global contract development and manufacturing organization for cell and gene therapies. The strategic partnership aims to offer fully integrated logistics
